• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在麻醉犬中比较经心外膜和静脉内给予腺嘌呤核苷的消除和心血管作用。

Comparison of elimination and cardiovascular effects of adenine nucleosides administered intrapericardially or intravenously in anesthetized dog.

机构信息

Heart Center, Semmelweis University, Budapest 1122, Hungary.

出版信息

J Cardiovasc Pharmacol. 2009 Oct;54(4):341-7. doi: 10.1097/FJC.0b013e3181b7674b.

DOI:10.1097/FJC.0b013e3181b7674b
PMID:19687746
Abstract

Intrapericardial (IP) administration of certain cardioactive agents allows investigation of local pharmacological actions on the heart and may carry potential benefit to influence myocardial function. The cardioprotective adenosine (ADO) and inosine (INO) may be the most representative candidates. Elimination and cardiovascular effects of IP and intravenously (IV) applied ADO and INO were compared on anesthetized dogs. Their pericardial and systemic concentrations were measured after consecutive administration of increasing ADO and INO doses. In the case of IP administration at the end of the incubation period, pericardial concentrations of adenine nucleosides significantly exceeded the control values. However, the IV applied ADO and INO were rapidly metabolized in the systemic plasma. As characteristic hemodynamic effects, small but sustained decrease in heart rate (IP ADO) and increase in myocardial contractility (IP INO) were observed. During IV administration, ADO and INO exerted remarkable effects on all hemodynamic variables, which then gradually disappeared in 15 minutes. In summary, the elimination of ADO and INO was significantly slower in the pericardial fluid than in the plasma. Considering the balanced cardiac actions and lack of strong systemic hemodynamic effects, IP administration of adenine nucleosides may suggest a promising approach in the local treatment of the diseased heart.

摘要

心包内(IP)给予某些心脏活性药物可研究局部药理作用于心脏,并可能对影响心肌功能具有潜在益处。具有心脏保护作用的腺苷(ADO)和肌苷(INO)可能是最具代表性的候选药物。在麻醉犬上比较了 IP 和静脉内(IV)给予的 ADO 和 INO 的消除和心血管作用。在连续给予递增剂量的 ADO 和 INO 后,测量其心包和全身浓度。在孵育期结束时进行 IP 给药的情况下,嘌呤核苷的心包浓度显著超过对照值。然而,IV 给予的 ADO 和 INO 在全身血浆中迅速代谢。作为特征性的血液动力学效应,观察到心率(IP ADO)略有但持续降低和心肌收缩力(IP INO)增加。在 IV 给予期间,ADO 和 INO 对所有血液动力学变量均产生显著影响,然后在 15 分钟内逐渐消失。总之,ADO 和 INO 在心包液中的消除明显比在血浆中慢。考虑到心脏作用平衡且无强烈的全身血液动力学作用,心包内给予嘌呤核苷可能提示局部治疗患病心脏的一种很有前途的方法。

相似文献

1
Comparison of elimination and cardiovascular effects of adenine nucleosides administered intrapericardially or intravenously in anesthetized dog.在麻醉犬中比较经心外膜和静脉内给予腺嘌呤核苷的消除和心血管作用。
J Cardiovasc Pharmacol. 2009 Oct;54(4):341-7. doi: 10.1097/FJC.0b013e3181b7674b.
2
Intrapericardial adenine nucleosides induce elevation of endothelin-1 concentration in the pericardial space of the dog heart.
J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S227-30. doi: 10.1097/01.fjc.0000166257.89357.7d.
3
Endothelin-1-induced elevations in purine metabolite concentrations -- autoregulatory protection in the canine pericardium?
Clin Sci (Lond). 2002 Aug;103 Suppl 48:202S-205S. doi: 10.1042/CS103S202S.
4
Pericardial concentrations of adenosine, inosine and hypoxanthine in an experimental canine model of spastic ischaemia.痉挛性缺血实验犬模型中心包内腺苷、肌苷和次黄嘌呤的浓度
Clin Sci (Lond). 2002 Aug;103 Suppl 48:198S-201S. doi: 10.1042/CS103S198S.
5
Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).一种新型强心剂MDL 17,043(1,3 - 二氢 - 4 - 甲基 - 5 - [4 - (甲硫基) - 苯甲酰基] - 2H - 咪唑 - 2 - 酮)的心血管特性
J Cardiovasc Pharmacol. 1982 May-Jun;4(3):500-8.
6
Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart.
Exp Biol Med (Maywood). 2006 Jun;231(6):847-51.
7
Cardiovascular properties of a new cardiotonic agent, MDL 19205.
J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):35-42.
8
Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart.CD73、核苷转运体和肌苷参与在发育中心脏中由腺苷 A1 和 A2A 受体介导的节律和传导障碍。
J Mol Cell Cardiol. 2013 Oct;63:14-25. doi: 10.1016/j.yjmcc.2013.06.008. Epub 2013 Jul 6.
9
Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.(2RS,3SR)-2-氨甲基-2,3,7,8-四氢-2,3,5,8,8-五甲基-6H-呋喃并[2,3-e]吲哚-7-酮盐酸盐(UK-1745)的心血管效应,一种具有血管舒张和抗心律失常特性的新型强心剂。
Arzneimittelforschung. 1998 Mar;48(3):219-31.
10
Cardiovascular effects of vasopressors in isoflurane-anesthetized dogs before and after hemorrhage.出血前后血管升压药对异氟烷麻醉犬的心血管影响。
Am J Vet Res. 1989 Nov;50(11):1866-71.